H. Saito et al., Allergen-induced murine upper airway inflammation: local and systemic changes in murine experimental allergic rhinitis, IMMUNOLOGY, 104(2), 2001, pp. 226-234
The role of inflammatory effector cells in the pathogenesis of airway aller
gy has been the subject of much investigation. However, whether systemic fa
ctors are involved in the development of local responses in both upper and
lower airways has not been fully clarified. The present study was performed
to investigate aspects of the pathogenesis of isolated allergic rhinitis i
n a murine model sensitized to ovalbumin (OVA). Both upper- and lower-airwa
y physiological responsiveness and inflammatory changes were assessed, as w
ell as bone marrow progenitor responses, by culture and immunohistological
methods. Significant nasal symptoms and hyper-responsiveness appeared after
intranasal OVA challenge (P < 0.0001 and P < 0.01, respectively), accompan
ied with significant nasal mucosal changes in CD4(+) cells (P < 0.001), int
erleukin (IL)-4(+) cells (P < 0.01), IL-5(+) cells (P < 0.01), basophilic c
ells (P < 0.02) and eosinophils (P < 0.001), in the complete absence of hyp
er-responsiveness or inflammatory changes in the lower airway. In the bone
marrow, there were significant increases in CD34(+) cells, as well as in eo
sinophils and basophilic cells. In the presence in vitro of mouse recombina
nt IL-5, IL-3 or granulocyte-macrophage colony-stimulating factor (GM-CSF),
the level of bone marrow eosinophil/basophil (Eo/Baso) colony-forming cell
s increased significantly in the OVA-sensitized group. We conclude that, in
this murine model of allergic rhinitis, haemopoietic progenitors are upreg
ulated, which is consistent with the involvement of bone marrow in the path
ogenesis of nasal mucosal inflammation. Both local and systemic events, ini
tiated in response to allergen provocation, may be required for the pathoge
nesis of allergic rhinitis. Understanding these events and their regulation
could provide new therapeutic targets for rhinitis and asthma.